This P30 application represents the culmination of years of an Indiana University School of Medicine (IUSM) effort to build its diabetes and obesity research base and to focus on specific basic science and translational research themes that represent areas of national priority. An important component of this application is the inclusion of collaborative researchers at nearby Purdue University, whose programs in obesity, nutrition, and biomedical engineering are complementary to the research themes at IUSM. Support of this P30 application will bolster diabetes research in Indiana by providing a dedicated resource that allows diabetes research and educational activities to be centralized and focused on the fundamental themes of our Research Base, that subsidizes Research Core services to encourage their use for innovation and translation, and that permits innovative research support for new investigators to maintain a pipeline of talented diabetes-oriented researchers. The mission of the Indiana Diabetes Research Center (IDRC) is to foster knowledge, support training, and promote basic and translational research in diabetes and related metabolic disorders, and their complications. The IDRC consists of a Research Base of 64 highly collaborative investigators at Indiana University School of Medicine and nearby Purdue University, whose research collectively will be augmented by 5 state-of-the-art Research Cores (Islet, Rodent, Microscopy, Swine, and Translation Cores). An Enrichment Program, supported by 5 T32 training grants, will enhance learning and discovery. A Pilot and Feasibility Program will grow the Research Base by providing funding to highly promising young investigators. An Administrative Core will oversee governance of the IDRC, and will receive input from an Executive Committee, an Internal Advisory Board, and an External Advisory Board of world-renowned diabetes/metabolism research leaders.
The Aims of the IDRC will be to (1) Promote high impact scientific discoveries by establishing Research Cores that facilitate collaborations and the use of state-of-the-art methodologies and human studies in diabetes research; (2) Enhance a highly collaborative environment that promotes learning and encourages interaction among investigators; (3) Support the training and innovative research of a burgeoning pool of superb investigators with the potential to become future leaders in diabetes research; (4) Build and strengthen the diabetes research base, support infrastructure to ensure ongoing growth and innovation, and engage with the local community to raise diabetes awareness and involvement.

Public Health Relevance

It is estimated that nearly 10% of the US population has diabetes, and the percentage with obesity and pre- diabetes is alarmingly higher. A goal of the Indiana Diabetes Research Center is to leverage resources, a highly talented pool of basic and translational researchers, and a rich environment of learning and collaboration to tackle the causes, diagnoses, and treatment of diabetes and related metabolic disorders and their complications.

National Institute of Health (NIH)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Center Core Grants (P30)
Project #
Application #
Study Section
Special Emphasis Panel (ZDK1-GRB-S (J4))
Program Officer
Hyde, James F
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Indiana University-Purdue University at Indianapolis
Schools of Medicine
United States
Zip Code
Chen, Melinda E; Chandramouli, Aaditya G; Considine, Robert V et al. (2018) Comparison of ?-Cell Function Between Overweight/Obese Adults and Adolescents Across the Spectrum of Glycemia. Diabetes Care 41:318-325
Aslamy, Arianne; Oh, Eunjin; Ahn, Miwon et al. (2018) Exocytosis Protein DOC2B as a Biomarker of Type 1 Diabetes. J Clin Endocrinol Metab 103:1966-1976
Dong, X Charlie (2018) SCP4: A Small Nuclear Phosphatase Having a Big Effect on FoxOs in Gluconeogenesis. Diabetes 67:23-25
Anjanappa, M; Hao, Y; Simpson, E R et al. (2018) A system for detecting high impact-low frequency mutations in primary tumors and metastases. Oncogene 37:185-196
Sims, Emily K; Evans-Molina, Carmella; Tersey, Sarah A et al. (2018) Biomarkers of islet beta cell stress and death in type 1 diabetes. Diabetologia 61:2259-2265
RISE Consortium (2018) Impact of Insulin and Metformin Versus Metformin Alone on ?-Cell Function in Youth With Impaired Glucose Tolerance or Recently Diagnosed Type 2 Diabetes. Diabetes Care 41:1717-1725
Lakshmikanthan, Sribalaji; Sobczak, Magdalena; Li Calzi, Sergio et al. (2018) Rap1B promotes VEGF-induced endothelial permeability and is required for dynamic regulation of the endothelial barrier. J Cell Sci 131:
Simons, Zachary B; Morgan, Rachel C; Rose, Laurel et al. (2018) Hypoglycemia in a Patient With a Polyhormonal Pancreatic Neuroendocrine Tumor With Evidence of Endocrine Progenitors. J Endocr Soc 2:172-177
Badin, Jill K; Kole, Ayeeshik; Stivers, Benjamin et al. (2018) Alloxan-induced diabetes exacerbates coronary atherosclerosis and calcification in Ossabaw miniature swine with metabolic syndrome. J Transl Med 16:58
Tersey, Sarah A; Levasseur, Esther M; Syed, Farooq et al. (2018) Episodic ?-cell death and dedifferentiation during diet-induced obesity and dysglycemia in male mice. FASEB J :fj201800150RR

Showing the most recent 10 out of 117 publications